Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
“Low-T” Drug Ads and Unnecessary Prescriptions Need to be Curbed by FDA, Experts Say June 18, 2015 Austin Kirk Add Your Comments If government regulators want to stop unnecessary testosterone prescriptions, they need to go after the aggressive direct-to-consumer ads from pharmaceutical companies, which encourage men to seek medical treatment for “low T” if they are suffering symptoms consistent with the natural drop of testosterone levels as all men age, according to some experts. In an editorial published last week in the Washington Post, professors Steven Woloshin and Lisa M. Schwartz called for the FDA to do more than require label warnings about potential “low T” drug side effects. Instead, they said the agency needs to act against ongoing advertisements that lead men to believe their natural low testosterone levels are a problem. In March, the FDA issued a testosterone drug safety communication, announcing label changes that would include warnings that there is evidence of a link between low T drugs and heart problems. In addition, the agency required warnings that the medications should only be used by men with diagnosed hypogonadism, which causes unnaturally low testosterone levels, and encouraged doctors not to prescribe the drug for so-called “life-style” reasons, such as addressing decreased energy levels or sexual drive. Learn More About Testosterone Lawsuits Testosterone Gel, Patches, Injections or other Treatments May Cause Heart Attacks, Strokes, Wrongful Death. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Testosterone Lawsuits Testosterone Gel, Patches, Injections or other Treatments May Cause Heart Attacks, Strokes, Wrongful Death. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Professors Woloshin and Schwartz said that the warnings came at least seven years, 25 million prescriptions, and $9.7 billion in sales too late, and asked why the FDA did not put a stop to AbbVie’s “Is it Low-T?” ads years ago, which helped turn Androgel into a blockbuster treatment, even though testosterone replacement therapy was initially expected to be a niche treatment. The professors say the campaigns have urged men to get checked for testosterone levels if they experienced such commonplace symptoms as gaining weight, feeling sad or grumpy, or got sleepy after meals. The editorial says the FDA claimed it was powerless to stop the ads, which the professors dispute. They also point out that the FDA could have referred the issue to the Federal Trade Commission if the agency did not have the regulatory power to interfere with the ad campaign. The campaign was one of many by pharmaceutical companies which were clear violations of laws forbidding “off-label” promotion of drugs for uses not approved by the FDA, according to the professors. They urged the agency to go after any “disease awareness” campaigns that were stealth off-label promotions. Last month, European researchers called for changes to the clinical guidelines used in testosterone testing, saying that current testing procedures were inaccurate. The concerns were raised after a study presented at the European Congress of Endocrinology in Dublin, Ireland, found that some symptoms identified with hypogonadism by current testing procedures led to misdiagnoses of men who did not suffer from the problem, which is caused by injury or damage to the testicles or certain parts of the brain. The researchers concluded that men with low but natural testosterone levels were being misdiagnosed and unnecessarily placed on testosterone drugs. Low T Drug Heart Risks The editorial comes amid continuing concerns over the potential heart risks with testosterone replacement therapy, as several recent studies have suggested that certain men may be more likely to experience a sudden heart attack, stroke, blood clot or death while using the popular low T drugs. In November 2013, research published in the Journal of the American Medical Association (JAMA) found that older men who began taking testosterone drugs following coronary angiography were more likely to suffer cardiovascular events, such as a heart attack, stroke or death. That study was followed by additional research published in the medical journal PLoSOne in January 2014, which found that side effects of testosterone drugs may double the risk of heart attacks for men over the age of 65, regardless of their prior health condition, as well as double the risk for younger men with a prior history of heart disease. In January 2015, another study published in the medical journal Pharmacotherapy found that first time testosterone users may be 40% more likely to have a heart attack when compared to men who did not use the drugs. Over the past year, a steadily growing number of men nationwide have filed an Androgel lawsuit, Testim lawsuits, Axiron lawsuit or other low T drug lawsuits after suffering a heart attack, stroke, pulmonary embolism, deep vein thrombosis or other injury allegedly caused by use of the drugs. All of the complaints involve similar allegations that drug makers manufactured the disease of “low T” through aggressive marketing, resulting in men using the prescription drugs when they had no real medical need. Plaintiffs claim that if the manufacturers had warned about the risk of testosterone health problems, severe and sometimes fatal injuries may have been avoided. In the federal court system, the testosterone litigation has been centralized as part of an MDL, or Multidistrict Litigation, for coordinated pretrial proceedings. A small group of Androgel cases are being prepared for trial. Known as “bellwether” cases, a series of six trials are scheduled to begin about one-per-month between October 2016 and April 2017, to help gauge how juries may respond to certain evidence and testimony that is likely to be offered throughout the litigation. Tags: AbbVie, AndroGel, Heart Attack, Stroke, Testosterone Image Credit: | More Testosterone Lawsuit Stories Link Between Testosterone Drugs and Heart Risks Not Found in New Study June 19, 2023 Study’s Findings Question Link Between Testosterone Drugs and Blood Clots October 26, 2021 New Testosterone Guidelines Warn Against Unnecessary Use, Prefer Shots Over Transdermal Products January 10, 2020 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermEmailThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Reckitt Benckiser Faces Class Action Lawsuit Over Enfamil NEC Risks (Posted: today) A class action lawsuit filed against the makers of Enfamil say the company misled investors by concealing the fact that the cow’s milk-based infant formula increased the risk of NEC. MORE ABOUT: ENFAMIL AND SIMILAC BABY FORMULA LAWSUITNEC Infant Formula Lawyers To Meet With MDL Judge Following Dismissal of First Bellwether Trial (05/29/2025)FDA To Investigate Whether Infant Formula Products Provide Enough Nutrition (05/16/2025)Expert Witnesses Linking Baby Formula and NEC Cleared for Trial, Despite Dismissal of First Bellwether Lawsuit (05/05/2025) Replacement Hair Relaxer Lawsuit To Be Selected for MDL Bellwether Pool (Posted: today) A federal judge has directed hair relaxer manufacturers to select a replacement case for the bellwether trial pool, following the plaintiff’s voluntary dismissal of one of the previously selected lawsuits. MORE ABOUT: HAIR RELAXER LAWSUITHair Relaxer Lawsuits and Talcum Powder Lawsuits Designated as New Mass Torts in Philadelphia (05/30/2025)Hair Relaxer Lawsuits MDL Judge Seeks Status Report on Discovery Proceedings (05/21/2025)Formaldehyde Found in Range of Personal Care Products Used Primarily by Black and Latina Women (05/14/2025) Reports Highlight Sports Betting Addiction Problems Among Young Men (Posted: yesterday) Sports betting sites are fostering gambling addiction in young men nationwide, according to recent reports. MORE ABOUT: SPORTS BETTING ADDICTION LAWSUITLawsuit Alleges DraftKings Daily Fantasy Games Constitute Illegal Sports Gambling in California (06/05/2025)DraftKings Faces Lawsuit Over Failure To Pay Winning Bets (05/29/2025)Teen Gambling Problems Frequently Start With Online Sportsbook Betting: Study (05/16/2025)
New Testosterone Guidelines Warn Against Unnecessary Use, Prefer Shots Over Transdermal Products January 10, 2020
Reckitt Benckiser Faces Class Action Lawsuit Over Enfamil NEC Risks (Posted: today) A class action lawsuit filed against the makers of Enfamil say the company misled investors by concealing the fact that the cow’s milk-based infant formula increased the risk of NEC. MORE ABOUT: ENFAMIL AND SIMILAC BABY FORMULA LAWSUITNEC Infant Formula Lawyers To Meet With MDL Judge Following Dismissal of First Bellwether Trial (05/29/2025)FDA To Investigate Whether Infant Formula Products Provide Enough Nutrition (05/16/2025)Expert Witnesses Linking Baby Formula and NEC Cleared for Trial, Despite Dismissal of First Bellwether Lawsuit (05/05/2025)
Replacement Hair Relaxer Lawsuit To Be Selected for MDL Bellwether Pool (Posted: today) A federal judge has directed hair relaxer manufacturers to select a replacement case for the bellwether trial pool, following the plaintiff’s voluntary dismissal of one of the previously selected lawsuits. MORE ABOUT: HAIR RELAXER LAWSUITHair Relaxer Lawsuits and Talcum Powder Lawsuits Designated as New Mass Torts in Philadelphia (05/30/2025)Hair Relaxer Lawsuits MDL Judge Seeks Status Report on Discovery Proceedings (05/21/2025)Formaldehyde Found in Range of Personal Care Products Used Primarily by Black and Latina Women (05/14/2025)
Reports Highlight Sports Betting Addiction Problems Among Young Men (Posted: yesterday) Sports betting sites are fostering gambling addiction in young men nationwide, according to recent reports. MORE ABOUT: SPORTS BETTING ADDICTION LAWSUITLawsuit Alleges DraftKings Daily Fantasy Games Constitute Illegal Sports Gambling in California (06/05/2025)DraftKings Faces Lawsuit Over Failure To Pay Winning Bets (05/29/2025)Teen Gambling Problems Frequently Start With Online Sportsbook Betting: Study (05/16/2025)